2022년 January 24일

Duchenne 근이영양증 치료 시장 동향, 문제, 과제, 예측, 경쟁 분석 및 관련 회사.

Global Duchenne Muscular Dystrophy Treatment Market Size research report 2021 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.

This study provides information about the sales and revenue during the historic and forecasted period of (2021 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Duchenne Muscular Dystrophy Treatment Market report.

In February 2019, a new investigational drug candidate, edasalonexent (CAT-1004), an oral inhibitor of NF-κB inhibitor, cleared the Phase 1 clinical trials, which was conducted on male patients and the drug candidate showed the potential to slow the progression of the disease

Get a Sample Copy of the Report at – www.fortunebusinessinsights.com/enquiry/request-sample-pdf/101863

Important Features that are under Offering and Key Highlights of the Market Report:

  • Detailed overview of the global market share
  • Changing market dynamics of the industry
  • In-depth market segmentation by Type, Application, etc.
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape of Duchenne Muscular Dystrophy Treatment Market
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising market growth

Drivers & Restraints

One of the key drivers of the growth of the duchenne muscular dystrophy treatment was the approval of Eteplirsen in 2016. Also, in June 2019 the Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Emflaza (deflazacort) by PTC Therapeutics, Inc., to expand its labelling that will include duchenne muscular dystrophy patients aged between 2 to 5 years. This combined with the strong pipeline of products under clinical trials, are anticipated to drive the growth of the duchenne muscular dystrophy (DMD) treatment market.

Key players covered in the global Duchenne Muscular Dystrophy Treatment Market research report:

BioMarin, Bristol-Myers Squibb Company, FibroGen, Inc., Nobelpharma Co., Ltd., NIPPON SHINYAKU CO. LTD., Pfizer Inc., SANTHERA PHARMACEUTICALS, Sarepta Therapeutics and Eli Lilly and Company and other players.

For More Detailed Information, Speak to Our Analyst at – www.fortunebusinessinsights.com/enquiry/speak-to-analyst/101863

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Major Table of Contents for Duchenne Muscular Dystrophy Treatment Market Research Report:

  • Introduction
  • Executive Summary
  • Market Dynamics
  • 주요 시장 성장 통찰력
  • 글로벌 시장 분석, 통찰력 및 예측, 2017-2028
  • 북미 시장 분석, 통찰력 및 예측, 2017-2028
  • 유럽 ​​시장 분석, 통찰력 및 예측, 2017-2028
  • 아시아 태평양 시장 분석, 통찰력 및 예측, 2017-2028
  • 중동 및 아프리카 시장 분석, 통찰력 및 예측, 2017-2028
  • 라틴 아메리카 시장 분석, 통찰력 및 예측, 2017-2028
  • 경쟁 구도
  • 글로벌 Duchenne 근이영양증 치료 시장 수익 성장, 주요 업체별 산업 점유율 분석, 2021
  • 회사 프로필
  • 결론

전체 보고서 구매  –  www.fortunebusinessinsights.com/checkout-page/101863

관련 보고서:

스텐트 시장  데이터 현재 및 미래 동향, 산업 규모, 점유율, 수익, 2028년까지 예측되는 비즈니스 성장

송곳니 관절염 치료 시장  최신 산업 규모, 성장, 점유율, 수요, 동향, 경쟁 환경 및 2028년 예측

 2028년까지 수의학 참조 실험실 시장 규모, 전망, 지리적 세분화, 비즈니스 과제 및 기회

000

회사 소개:

Fortune Business Insights™는 정확한 데이터와 혁신적인 기업 분석을 제공하여 모든 규모의 조직이 적절한 결정을 내릴 수 있도록 지원합니다. 우리는 고객을 위해 새로운 솔루션을 맞춤화하여 고객이 비즈니스 고유의 다양한 문제를 해결할 수 있도록 지원합니다. 우리의 목표는 그들이 운영하는 시장에 대한 세분화된 개요를 제공하여 전체적인 시장 인텔리전스를 제공하는 것입니다.

문의하기:

Fortune Business Insights™ Pvt. 주식회사

308, 최고 본부,

설문 조사 번호 36, Baner,

푸네-방갈로르 고속도로,

푸네 – 411045, 마하라슈트라, 인도.

핸드폰:

미국:+1 424 253 0390

영국: +44 2071 939123

아시아태평양: +91 744 740 1245

이메일:  [email protected]